BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 8611458)

  • 1. Multidrug resistance P-glycoprotein function of bone marrow hematopoietic cells and the reversal agent effect.
    Chen Z; Takeshita A; Zou P; Liu Z; Kozaka M; You Y; Song S; Ohnishi K; Ohno R
    J Tongji Med Univ; 1999; 19(4):260-3. PubMed ID: 12938512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNFα induces Caspase-3 activity in hematopoietic progenitor cells CD34+, CD33+, and CD41 + of myelodysplastic syndromes.
    Iriani A; Rachman A; Setiabudy RD; Kresno SB; Sudoyo AW; Arief M; Harahap AR; Fatina MK
    BMC Mol Cell Biol; 2023 Nov; 24(1):33. PubMed ID: 37990142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialic acid-binding immunoglobulin-like lectin (Sigelac)-15 is a rapidly internalised cell-surface antigen expressed by acute myeloid leukaemia cells.
    Cao H; Neerincx A; de Bono B; Lakner U; Huntington C; Elvin J; Gudgin E; Pridans C; Vickers MA; Huntly B; Trowsdale J; Barrow AD
    Br J Haematol; 2021 Jun; 193(5):946-950. PubMed ID: 33951750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent.
    Takeshita A; Shinjo K; Naito K; Matsui H; Sahara N; Shigeno K; Suzumura T; Horii T; Shirai N; Maekawa M; Yada Y; Teshima H; Takeuchi J; Ohnishi K; Ohno R
    Int J Hematol; 2005 Dec; 82(5):445-8. PubMed ID: 16533750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multidrug resistance in acute leukemia].
    Takeshita A; Ohno R
    Rinsho Ketsueki; 1996 Aug; 37(8):640-6. PubMed ID: 8827870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers.
    Matsui H; Takeshita A; Naito K; Shinjo K; Shigeno K; Maekawa M; Yamakawa Y; Tanimoto M; Kobayashi M; Ohnishi K; Ohno R
    Leukemia; 2002 May; 16(5):813-9. PubMed ID: 11986941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.
    Virgo P; Denning-Kendall PA; Erickson-Miller CL; Singha S; Evely R; Hows JM; Freeman SD
    Br J Haematol; 2003 Nov; 123(3):420-30. PubMed ID: 14617000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines.
    Naito K; Takeshita A; Shigeno K; Nakamura S; Fujisawa S; Shinjo K; Yoshida H; Ohnishi K; Mori M; Terakawa S; Ohno R
    Leukemia; 2000 Aug; 14(8):1436-43. PubMed ID: 10942240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.
    Drach D; Zhao S; Drach J; Mahadevia R; Gattringer C; Huber H; Andreeff M
    Blood; 1992 Dec; 80(11):2729-34. PubMed ID: 1360266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug resistance P-glycoprotein in myeloid progenitor cells of different phenotype: comparison between normal bone marrow cells and leukaemia cells.
    Takeshita A; Shinjo K; Ohnishi K; Ohno R
    Br J Haematol; 1996 Apr; 93(1):18-21. PubMed ID: 8611458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MDR1 by normal bone marrow cells and its implication for leukemic hematopoiesis.
    Drach J; Zhao S; Drach D; Körbling M; Engel H; Andreeff M
    Leuk Lymphoma; 1995 Feb; 16(5-6):419-24. PubMed ID: 7540457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor receptor at various differentiation stages of normal and leukemic hematopoietic cells.
    Shinjo K; Takeshita A; Ohnishi K; Ohno R
    Leuk Lymphoma; 1997 Mar; 25(1-2):37-46. PubMed ID: 9130612
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.